Late-Breaking Science-2
Late-Breaking Science-2
11/22 13:30-15:30
103A (103A)
-
13:30- 15:30主持Kalyanam SHIVKUMAR (UCLA Medical Center), Sergio Raposeiras ROUBIN (University Hospital Alvaro Cunqueiro - Vigo, Spain), Myeong-Ki HONG (Yonsei University), Jeehoon KANG (Seoul National University Hospital, Republic of Korea), 陈绍良(CHEN Shao-Liang) (南京市第一医院), 杜昕(DU Xin) (首都医科大学附属北京安贞医院), 朱云鹏(ZHU Yun-Peng) (上海交通大学医学院附属瑞金医院)
-
13:30-13:50Endovenous Radiofrequency Ablation of Great Saphenous Varicose Vein: A Prospective Multicenter Randomized Controlled StudyEndovenous Radiofrequency Ablation of Great Saphenous Varicose Vein: A Prospective Multicenter Randomized Controlled Study
-
13:50-14:10Prognostic Implications of Plaque and Hemodynamic Characteristics for Risk of Future Acute Coronary Syndrome According to Lesion MultiplicityPrognostic Implications of Plaque and Hemodynamic Characteristics for Risk of Future Acute Coronary Syndrome According to Lesion Multiplicity
-
14:10-14:30Who Benefits from Angiography-derived FFR-Guided Revascularization? Defining the Beneficial Population and Its Key FeaturesWho Benefits from Angiography-derived FFR-Guided Revascularization? Defining the Beneficial Population and Its Key Features
-
14:30-14:50Real-time Evaluation and Anticipation of Causal disTillation Early Prediction for Cardiac Surgery-Associated Acute Kidney Injury (REACT-01) : a Single-Center Prospective Randomized Clinical TrialReal-time Evaluation and Anticipation of Causal disTillation Early Prediction for Cardiac Surgery-Associated Acute Kidney Injury (REACT-01) : a Single-Center Prospective Randomized Clinical Trial
-
14:50-15:10Mortality Risk Stratification Using Electrocardiogram-Based Machine Learning for Patients in the Emergency DepartmentMortality Risk Stratification Using Electrocardiogram-Based Machine Learning for Patients in the Emergency Department
-
15:10-15:30Efficacy and Safety of Alpha-Lipoic Acid in Patients with Ischemic Heart Failure: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group StudyEfficacy and Safety of Alpha-Lipoic Acid in Patients with Ischemic Heart Failure: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study